KRAS and pancreatic adenocarcinoma: The dominant missense point mutation differs across cancers; for example, KRAS G12D is the dominant mutant subtype in pancreatic adenocarcinoma at 67.6%, and G12D and G12V are the most common mutations in colorectal carcinoma, representing 39% and 24%, respectively [14].